Results 211 to 220 of about 94,577 (347)

Baths salts, spice, and related designer drugs: the science behind the headlines. [PDF]

J Neurosci, 2014
Baumann MH, Solis E, Watterson LR, Marusich JA, Fantegrossi WE, Wiley JL.   +5 more
europepmc   +1 more source

METHOXPHENIDINE, A DESIGNER DRUG OR A POSSIBLE ROUTE FOR RESEARCH TO DEPRESSION TREATMENT?

Bronislav Jurásek, Magdaléna Vágnerová, Hana Walaská, Kristýna Mazochová, Martin Kuchař   +4 more
openalex   +1 more source

Isomeric Analysis of Synthetic Cannabinoids Detected as Designer Drugs

, 2011
Nahoko Uchiyama, Ruri Kikura‐Hanajiri, Takuji Shoda, Kiyoshi Fukuhara, Yukihiro Goda   +4 more
openalex   +2 more sources

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Fragmentation Pathways of Trifluoroacetyl Derivatives of Methamphetamine, Amphetamine, and Methylenedioxyphenylalkylamine Designer Drugs by Gas Chromatography/Mass Spectrometry [PDF]

, 2011
Takeshi Kumazawa, Kenji Hara, Chika Hasegawa, Seisaku Uchigasaki, Xiao‐Pen Lee, Hiroshi Seno, Osamu Suzuki, Keizo Sato   +7 more
openalex   +1 more source

The Cord Weekly (February 7, 2001) [PDF]

, 2001

core   +1 more source

A practical approach [PDF]

, 2020
Kollmeier, Annette Sophie, Parr, Maria Kristina   +1 more
core   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Death Following Recreational Use of Designer Drug “Bath Salts” Containing 3,4-Methylenedioxypyrovalerone (MDPV) [PDF]

, 2012
Brittany Murray, Christine Murphy, Michael C. Beuhler   +2 more
openalex   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source